It was concluded that both of the IL2RA gene polymorphisms, rs2104286 and rs12722489, were associated with increased susceptibility to MS.
This meta-analysis studied the association between interleukin 2 receptor a (IL2RA) gene polymorphisms rs2104286 and rs12722489 and susceptibility to multiple sclerosis (MS). Case-control genetic association studies published before January 2011 were retrieved from the PubMed and EMBASE databases and the Cochrane Library. Eight studies comprising 13 569 patients and 23 435 controls met the selection criteria for metaanalysis of the IL2RA rs2104286 polymorphism. Using a fixed-effects model, the T allele and the TT and TT + TC genotypes of the IL2RA rs2104286 polymorphism were found to be associated with MS. Five studies comprising 5643 patients and 6415 controls met the selection criteria for meta-analysis of the IL2RA rs12722489 polymorphism. Using a fixed-effects model, the C allele and the CC genotype of the IL2RA rs12722489 polymorphism were found to be associated with MS but the CC + CT genotype was not.
Introduction
Multiple sclerosis (MS) is a neuroinflammatory autoimmune disease characterized by multiple lesions of the central nervous system. 1, 2 It is the most common central nervous system disease in young adults and one of the leading causes of disability in this age group, affecting over 2.5 million individuals worldwide. 3 The pathogenesis of MS is not completely understood. It is a complex disease resulting from interactions between genetic and environmental factors. 4 -6 The genetic influence on MS susceptibility is substantial. For a long time, the only consistent factor associated with susceptibility to MS appeared to be the human leucocyte antigen (HLA)-DRB1 region, and complex allelic interactions of the HLA-DRB1 locus have been suggested. 7 This, however, accounts for < 50% of MS genetics. 8 Recent genome-wide association scan studies have revealed two additional genes that are associated with an increased risk of MS, the interleukin 7 receptor α (IL7RA) and the interleukin 2 receptor α (IL2RA) genes located on chromosomes 5p13 and 10p15, Interleukin 2 receptor a gene polymorphism and risk of multiple sclerosis respectively. 9 Two single-nucleotide polymorphisms (SNPs) in the IL2RA gene, rs2104286 and rs12722489, were thought to be associated with MS. 9 Some studies have indicated that the 'T' allele of the IL2RA rs2104286 polymorphism and the 'C' allele of the IL2RA rs12722489 polymorphism were strongly associated with an increased risk of MS. 9 -15 Other studies have shown weak or no association between the IL7RA and IL2RA genes and susceptibility to MS. 16 -18 The present meta-analysis assessed whether the combined evidence in the literature demonstrates an association between the IL2RA rs2104286 and rs12722489 polymorphisms and susceptibility to MS.
Materials and methods

IDENTIFICATION OF ELIGIBLE STUDIES AND DATA EXTRACTION
Using PubMed, EMBASE and the Cochrane Library, an exhaustive search was performed for all studies that have examined a potential association between the interleukin-2 receptor (IL-2R) and MS. The following key words were used: 'interleukin-2 receptor', 'IL-2R', 'polymorphism' and 'multiple sclerosis'. No restrictions were placed on language, race, ethnicity or geographical area.
INCLUSION CRITERIA
The following inclusion criteria were used for the literature selection: (i) date of publication before January 2011; (ii) a case-control design; (iii) enough information to calculate the odds ratio (OR); and (iv) where the same population or research was published in multiple publications, the publication with the largest sample size was included. Only studies published in English were included in the analyses.
EXCLUSION CRITERIA
The following exclusion criteria were used for the literature selection: (i) studies in which family members had been studied; (ii) studies containing a small sample size or overlapping data; and (iii) incomplete data or where data could not be obtained by calculation.
DATA COLLECTION
Two investigators independently extracted the information. When there were conflicting evaluations an agreement was reached after discussion. The full texts of the candidate articles were examined carefully to determine whether or not they were in accordance with the inclusion criteria. For each study the following data were recorded: first author's surname, year of publication, country of origin, demographics, number of cases and controls, P-value, OR or relative risk, 95% confidence interval (CI) of the OR, and riskallele frequency of the IL2RA rs2104286 and rs12722489 polymorphisms.
STATISTICAL ANALYSES
For the IL2RA rs2104286 polymorphism, the effects of the T allele, the TT genotype (recessive effect), and the TT + TC genotypes (dominant effect) on the risk of MS were evaluated. For the IL2RA rs12722489 polymorphism, the effects of the C allele, the CC genotype (recessive effect), and the CC + CT genotypes (dominant effect) on the risk of MS were evaluated. The OR and 95% CIs were calculated for each study.
In consideration of the possibility of heterogeneity across the studies, a statistical test for heterogeneity was performed based on the Q-statistic. 19, 20 If the P-value was ≤ 0.05 for the Q-test, which indicates heterogeneity among the studies, the summary OR estimate of each study was calculated by the random-effects model (DerSimonian and Laird method). 21 If the P-Interleukin 2 receptor a gene polymorphism and risk of multiple sclerosis value was > 0.05, which indicates a lack of heterogeneity among the studies, the summary OR estimate of each study was calculated by the fixed-effects model (Mantel-Haenszel method). Funnel plots and Egger's linear regression test were used to assess any potential publication bias. 22 Statistical manipulations were performed using the Review Manager (RevMan) software package, version 5.0 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark) and the Stata software package, version 11.0 (StataCorp LP, College Station, TX, USA). The power of each study was considered as the probability of detecting an association between the IL2RA polymorphisms and MS, and was calculated at the 0.05 level of significance.
Results
STUDIES INCLUDED IN THE META-ANALYSIS
A total of 11 association studies related to the IL2RA polymorphism and susceptibility to MS were identified (the most recent article was dated February 2010). 9 -18,23 A total of 10 studies focused on the association between the IL2RA rs2104286 polymorphism and the risk of MS, 9 -18 whereas six studies focused on the association between the IL2RA rs12722489 polymorphism and the risk of MS. 9,11,13,16 -18 Other SNPs, such as the rs4129506, rs3528525 and rs1159465 polymorphisms in the IL2RA gene, were also evaluated for potential association with risk of MS 15, 16, 18, 23 but, in this meta-analysis, only studies that focused on two particular SNPs (IL2RA rs2104286 and IL2RA rs12722489) and susceptibility to MS were reviewed. One study was excluded because of unavailable data. 17 Another association study 23 was excluded because of overlapping data with other studies. 12, 13 A total of eight studies, comprising 13 569 MS patients and 23 435 controls, were retained for the meta-analysis of the IL2RA rs2104286 polymorphism and the risk of MS (Table 1) . 9 -12,14 -16,18 A total of five studies, comprising 5643 MS patients and 6415 controls, were retained for the meta-analysis of the IL2RA rs12722489 polymorphism and the risk of MS (Table 2) . 9, 11, 13, 16, 18 None of the frequency distributions for the genotypes studied deviated from the Hardy-Weinberg equilibrium of the controls.
IL2RA RS2104286 POLYMORPHISM AND MS
Combined ORs and 95% CIs for associations of the T allele, TT genotype and TT + TC genotype with the risk of MS were calculated. 9 -12,14 -16,18 Cochran's Q-statistic and the I 2 index were used to evaluate the heterogeneity between the studies. Heterogeneity was not found among the individual estimates of the ORs for the IL2RA rs2104286 T allele and MS (χ 2 = 8.10; P = 0.52; Fig 1A) , the TT genotype and MS (χ 2 = 6.69; P = 0.67; Fig. 1B ) and for the TT + TC genotype and MS (χ 2 = 5.06; P = 0.83; Fig.  1C ). The fixed-effects model was adopted to test the association between MS and the T allele, the TT genotype and the TT + TC genotype. The overall OR for the T allele was 1.17 (95% CI 1.13, 1.22; P < 0.00001; Fig.  1A ), for the TT genotype the overall OR was 1.20 (95% CI 1.15, 1.25; P < 0.00001; Fig. 1B ) and for the TT + TC genotype overall OR was 1.30 (95% CI 1.19, 1.43; P < 0.00001; Fig.  1C ).
Funnel plots for the studies showed significant symmetry (Fig. 2 ). Egger's test showed that there was no significant publication bias among the selected studies (for the T allele, t = 1.64, P = 0.14; for the TT genotype, t = -0.19, P = 0.855; and for the TT + TC genotype, t = 0.30, P = 0.77). 1.30 (1.19, 1.43) Cochran's Q-statistic and the I 2 index were used to evaluate the heterogeneity between the studies. 9, 11, 13, 16, 18 Heterogeneity was not Fig. 3A ), for the CC genotype and MS (χ 2 = 1.60; P = 0.81; Fig.  3B) , and for the CC + CT genotype and MS (χ 2 = 0.18; P = 1.00; Fig. 3C ). The fixed-effects model was adopted to test the association between MS and the C allele, the CC genotype and the CC + CT genotype. The overall OR for the C allele was 1.19 (95% CI 1.10, 1.28; P < 0.00001; Fig. 3A ), for the CC genotype the overall OR was 1.21 (95% CI 1.11, 1.31; P < 0.00001; Fig. 3B ) and for the CC + CT genotype the overall OR was 1.29 (95% CI 0.98, 1.69; P = 0.07; Fig. 3C ).
L-M Wang
Odds ratio M-H, Fixed, 95% CI
Funnel plots for the studies showed significant symmetry (Fig. 4) . Egger's test showed that there was no significant FIGURE 3: Odds ratios and 95% confidence intervals (CIs) of individual studies and pooled data for the association between the interleukin 2 receptor α (IL2RA) gene rs12722489 polymorphism C allele (A), CC genotype (B) and CC + TC genotype (C) and multiple sclerosis 
Discussion
The aetiology of MS remains elusive but the general consensus is that it involves both genetic and environmental factors. A large number of studies have identified many genes with differing contributions to the pathogenesis of MS. Among the suspected susceptibility genes, HLA-DRB1 on chromosome 6p21 is the most studied locus that contributes to genetic susceptibility to MS. 24 -27 The HLA-DRB1 gene does not, however, completely explain the genetic basis of the disease and accounts for < 50% of MS genetics. 3, 28 Many non-HLA genes have been suggested to have an association with MS but few of these proposed associations have shown reproducibility in different populations. 29, 30 Differences in the risk of development of MS with various IL2RA gene polymorphisms (> 20 SNPs are known) have been demonstrated, 9 -11,13 -15,17,31 although these studies have yielded conflicting results.
The present meta-analysis was performed to establish the relationship between the two SNPs of the IL2RA gene that appear to be most closely associated with susceptibility to MS, i.e. the rs2104286 and rs12722489 polymorphisms. A positive association was found between the IL2RA gene rs2104286 polymorphism and MS. Using a fixed-effects model, the T allele and the TT and TT + TC genotypes were all found to be associated with MS.
Studies on the association of the IL2RA rs12722489 polymorphism and risk of MS have also yielded conflicting results. 9, 11, 13, 16, 18 Some studies have reported that the IL2RA rs12722489 C allele was not associated with MS. 11, 13 The present meta-analysis demonstrated an association for this SNP with a risk of MS. Using a fixed-effects model, the C allele and the CC genotype were all found to be associated with MS but the CC + CT genotype was not.
Interleukin-2 is an essential T-cell growth factor that plays an important role in the function and proliferation of T lymphocytes. 32 There are three subunits of the IL-2R, including the IL-2RA subunit (also known as CD25). IL-2RA is present in high levels in T-regulatory cells and is encoded by the IL2RA gene on chromosome 10p15. 33, 34 Variation in this gene is associated with susceptibility to diseases with an autoimmune aetiology, including type 1 diabetes mellitus and Graves' disease. 35, 36 Maier et al. 15 first confirmed that the IL2RA rs2104286 C allele was associated with decreased soluble IL-2RA levels in serum. They also observed that soluble IL-2RA in serum can enhance the expansion and proliferation of CD4 + T-cells cultured ex vivo and that soluble IL-2RA inhibits IL-2 signalling in CD4 + FoxP3 + T-cells, as measured by phosphorylation of signal transducer and activator of transcription 5. 15 Taken together, these findings were used to develop an hypothesis that variations in IL-2RA protein may be involved in the pathogenesis of MS before disease onset and that strong genetic factors (such as the T allele in the IL2RA rs2104286 polymorphism) that affect the expression of the IL2RA gene are likely to modulate disease onset, potentially affecting the function of multiple lymphocyte subsets and associated disease risk. The complete sequence of causation is not yet clear. Thus, additional association studies in large cohorts as well as expression analyses will have to be performed to identify the mechanism by which variations in IL2RA gene expression affect susceptibility to diseases such as MS.
The main purpose of performing a metaanalysis is to improve statistical power and obtain more compelling results by increasing the sample size. There are, however, some • Received for publication 8 April 2011 • Accepted subject to revision 23 April 2011
• Revised accepted 6 August 2011 Copyright © 2011 Field House Publishing LLP limitations to this approach and there were several potential limitations to the present meta-analysis. First, MS is thought to originate from interactions between multiple genes, environmental factors and geneenvironment interactions, and even different polymorphic loci of the same gene may modulate the risk of MS 2,28,37 A more precise analysis could be conducted if more detailed individual data were available, which would allow for an adjusted estimate. Secondly, meta-analyses may be distorted by publication bias and heterogeneity. The funnel plots in the present analyses showed significant symmetry, indicating no significant publication bias. Heterogeneity was not observed when all studies were included in the meta-analysis but, because it was very difficult to obtain the full papers published in various languages, only studies published in English were included and this may have affected the final conclusions. Thirdly, the studies included were performed on European, Australian, and North American populations, but no studies were performed on Asian populations. There are wide variations in clinical presentation, incidence ratios in males to females and HLA typing between Asian and Western MS patients. 38 This regional limitation suggests that the final study conclusions may not reflect the association between IL2RA gene polymorphisms and the risk of MS in all populations.
